Table 3.1. Number and rates* of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2015–2019

Table 3.1. Number and rates* of reported cases of acute hepatitis C, by state or jurisdiction — United States, 2015–2019
Table 3.1. Number and rates* of reported cases† of acute hepatitis C, by state or jurisdiction — United States, 2015–2019
Source: CDC, National Notifiable Diseases Surveillance System.
Klevens RM, Liu, S, Roberts H, et al. Estimating acute viral hepatitis infections from nationally reported cases. Am J Public Health 2014;104:482. PMC3953761
* Rates per 100,000 population.
† Reported cases that met the classification criteria for a confirmed case. For the case definition, see https://ndc.services.cdc.gov/conditions/hepatitis-c-acute/.
—: No reported cases. The reporting jurisdiction did not submit any cases to CDC.
N: Not reportable. The disease or condition was not reportable by law, statute, or regulation in the reporting jurisdiction.
U: Unavailable. The data were unavailable.

Downloads of this table: PDF  PPT

See Table 3.3 for more risk behavior/exposure data.

The capacity of each jurisdiction for notifying CDC of acute hepatitis C cases varies considerably on the basis of laws, resources, and infrastructure for conducting viral hepatitis surveillance. During 2019, a total of 7 jurisdictions did not submit acute hepatitis C case notifications to CDC. The national rate of acute hepatitis C was 1.3 reported cases per 100,000 population during 2019, a >60% increase from the rate reported during 2015. Indiana had the highest reported rate of acute hepatitis C (4.8 cases per 100,000 population), whereas Florida reported the largest number of cases (n = 616). Seven states with the highest number of reported acute cases (Florida, Indiana, New York, Ohio, Pennsylvania, Tennessee, and California) accounted for >50% of the national burden of acute hepatitis C during 2019.

Hepatitis C Figures and Tables